Insider Transactions in Q1 2021 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2021
|
Lawrence Otto Klein CBO & COO |
SELL
Open market or private sale
|
Direct |
100,000
-89.52%
|
$12,700,000
$127.58 P/Share
|
|
Mar 23
2021
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
88,000
+20.38%
|
$2,904,000
$33.17 P/Share
|
|
Mar 22
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
30,374
-9.2%
|
$4,009,368
$132.28 P/Share
|
|
Mar 10
2021
|
Tony W Ho Executive VP, Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,141
-5.29%
|
$265,484
$124.15 P/Share
|
|
Mar 10
2021
|
Tony W Ho Executive VP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
4,583
+10.18%
|
-
|
|
Mar 10
2021
|
James R. Kasinger General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,353
-5.36%
|
$167,772
$124.15 P/Share
|
|
Mar 10
2021
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+10.08%
|
-
|
|
Mar 10
2021
|
Lawrence Otto Klein CBO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,141
-14.09%
|
$265,484
$124.15 P/Share
|
|
Mar 10
2021
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,583
+23.18%
|
-
|
|
Mar 10
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,526
-2.85%
|
$685,224
$124.15 P/Share
|
|
Mar 10
2021
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,833
+5.75%
|
-
|
|
Mar 10
2021
|
Michael John Tomsicek Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,352
-41.69%
|
$167,648
$124.15 P/Share
|
|
Mar 10
2021
|
Michael John Tomsicek Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+46.63%
|
-
|
|
Mar 05
2021
|
Tony W Ho Executive VP, Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,585
-4.23%
|
$180,690
$114.65 P/Share
|
|
Mar 05
2021
|
Tony W Ho Executive VP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+8.17%
|
-
|
|
Mar 01
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
798
-0.44%
|
$103,740
$130.25 P/Share
|
|
Mar 01
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
13,213
+9.14%
|
-
|
|
Mar 01
2021
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
338,165
-53.38%
|
-
|
|
Mar 01
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
60,068
+26.47%
|
-
|
|
Feb 19
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
47,536
+26.88%
|
-
|
|
Feb 19
2021
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
1,285,027
-57.39%
|
-
|
|
Feb 19
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
248,625
+31.17%
|
-
|
|
Feb 19
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
171,003
-12.77%
|
$25,479,447
$149.99 P/Share
|
|
Jan 19
2021
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
27,500
-14.51%
|
$5,637,500
$205.45 P/Share
|
|
Jan 19
2021
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
27,500
+35.52%
|
$1,402,500
$51.49 P/Share
|
|
Jan 15
2021
|
Lawrence Otto Klein CBO & COO |
SELL
Open market or private sale
|
Direct |
25,000
-6.68%
|
$5,375,000
$215.28 P/Share
|
|
Jan 15
2021
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,010
+27.12%
|
$325,130
$13.5 P/Share
|
|
Jan 15
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.71%
|
$4,280,000
$214.49 P/Share
|
|
Jan 15
2021
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.97%
|
$20,000
$1.81 P/Share
|
|
Jan 02
2021
|
Lawrence Otto Klein CBO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,392
-46.96%
|
$1,436,976
$153.11 P/Share
|